30 results
424B2
AQST
Aquestive Therapeutics Inc
24 Apr 24
Prospectus for primary offering
6:25am
infringement, securities, business torts, investigative, product safety or efficacy and antitrust litigation matters;
risk of product recalls
424B2
AQST
Aquestive Therapeutics Inc
24 Apr 24
Prospectus for primary offering
6:23am
infringement, securities, business torts, investigative, product safety or efficacy and antitrust litigation matters;
risk of product recalls
424B5
AQST
Aquestive Therapeutics Inc
21 Mar 24
Prospectus supplement for primary offering
4:06pm
, securities, investigative, product safety or efficacy and antitrust litigation matters;
risk of product recalls and withdrawals;
the COVID-19 pandemic … of significant customers;
risks related to claims and legal proceedings including patent infringement, securities, business torts, investigative, product
424B5
AQST
Aquestive Therapeutics Inc
19 Mar 24
Prospectus supplement for primary offering
5:18pm
including patent infringement, securities, business torts, investigative, product safety or efficacy and antitrust litigation matters;
risk of product … customers;
risks related to legal proceedings including patent infringement, securities, investigative, product safety or efficacy and antitrust
8-K
EX-99.2
7bddnyr5
14 Mar 24
Other Events
9:56pm
424B5
y43hn168dmxqr0lqxs
7 Sep 22
Prospectus supplement for primary offering
4:02pm
424B5
dkmg4e
8 Jun 22
Prospectus supplement for primary offering
9:07am
424B5
078e 25d5mqi
13 Apr 22
Prospectus supplement for primary offering
8:00am